Women's health is not just underfunded. It is under-translated.
Women's Health Foundry is a specialist national platform being developed by Proto Axiom to move more Australian women's health innovations from research into de-risked, investment-ready ventures and patient impact.
Backed by 33 investors including global business leaders.
Ecosystem momentum
Growing interest across Australia
Founders, researchers, partners, and investors are registering interest as the platform is developed.
The gap between discovery and patients is structural
Strong programs stall not because teams lack ambition, but because the next step is unclear: what to prove, in what sequence, to satisfy regulators, payers, and capital. Women's health ventures face particular complexity in endpoints, evidence standards, and adoption dynamics that generic programs rarely address.
Women's Health Foundry is being developed to close that gap: the expertise, capital, and commercial pathways needed to move research toward patients, not another open-ended grant round.
What makes this different
Five design choices that shape how the platform operates.
Specialist women's health focus
Category-specific milestones, evidence sequencing, and partner networks built for how these assets actually progress.
Active incubation, not grant administration
Hands-on support with decision-grade progress markers. Venture outcomes, not compliance paperwork.
Builder-operator model
Proto Axiom designs and runs the platform: operating model, milestone logic, and execution. Not passive capital.
National, virtual-first structure
Coordination and partner pathways not tied to a single building. In-person engagement where governance requires it.
Ecosystem integration
Built with universities, health services, consumers, industry, and investors. Shared infrastructure, not a competing parallel track.
Operating model at a glance
Five linked stages from selection through partner and capital pathways.
01
Source and select
Screen for unmet need, evidence maturity, and credible venture potential.
02
Stage 1 de-risking
Fund work that removes the next material uncertainties: technical, regulatory, or commercial.
03
Gate review
Formal checkpoint: advance, change scope, or stop. No capital spent on drift.
04
Stage 2 scale-up
Deeper build: evidence plan, operating plan, team gaps, and partner-ready materials.
05
Partner and capital pathways
Curated introductions when timing, diligence, and governance align.
National in scope
Women's health innovation is distributed across Australian institutions. The platform is designed to reach and support teams nationally — not tied to a single city or campus.
New South Wales
University of Sydney, UNSW, Sydney Biomedical Accelerator. Primary infrastructure and clinical partner hub.
Victoria
Monash University, University of Melbourne, Royal Women's Hospital. Deep strength in reproductive biology and maternal health.
Queensland
University of Queensland, QIMR Berghofer. Emerging programs in fertility research and clinical trials.
National network
Virtual-first coordination with in-person engagement where governance requires it. Partner pathways across SA, WA, TAS, and ACT institutions.
Partner institutions and state-level engagement are being finalised. The platform is designed for national reach from day one.
What founders receive
Concrete support structured around the recurring failure modes inwomen's health venture translation.
Milestone funding
Capital tied to defined de-risking steps, not undifferentiated runway.
Regulatory planning
Early mapping of classification, evidence expectations, and pathway risk.
Clinical trial design
Endpoint and study-shape choices matched to what investors and regulators care about next.
Commercial strategy
Who pays, how adoption happens, and what has to be true for the economics to work.
Mentor and advisory access
Structured access to people who have shipped in this category, not generic coaching.
Follow-on capital support
Positioning and introductions toward the next financing round when milestones warrant it.
Community in action
Building the ecosystem before the platform
Proto Axiom has been actively convening researchers, investors, and institutions around Australian biotech translation — creating the relationships and infrastructure that Women's Health Foundry is designed to scale.
$750K+
Researcher grants awarded
300+
Investors and clinicians convened
14
Live pitches at Pitch for Health 2026
2
Institutional co-hosts
Challenger Summit · 2024
National biotech pitch event
$250,000 in grants to early-stage researchers. Ten finalists from universities across Australia and New Zealand pitched to venture capitalists, industry leaders, and philanthropists.
Pitch for Health · March 2026
Co-hosted with St Vincent's Curran Foundation
Australia's largest medical and biotech pitch day. $500,000 in grants across two streams, with 300+ investors, clinicians, and industry leaders in Sydney.
AusBiotech · 2026
Women's health translation program
Co-designed joint program with Australia's peak biotech industry body, running August–September 2026 with initial emphasis on translational innovation in women's health.
Confirmed partnership
AusBiotech joint program
Proto Axiom and AusBiotech — Australia's peak biotechnology industry body representing 3,000+ members — are co-designing a joint program focused on translational innovation in women's health, running August–September 2026.
The program will connect researchers and early ventures with industry partners, regulatory expertise, and capital pathways through AusBiotech's national network — reinforcing the platform's commitment to building with the ecosystem, not alongside it.
Program structure and participation details will be announced when confirmed.
The ecosystem
Organisations working in this space
Australian universities, health systems, and industry bodies are active in women's health research and translation. Proto Axiom has worked with several of these institutions and continues to build relationships across the ecosystem.
These are organisations active in the Australian health and life sciences ecosystem. Listing does not imply formal partnership or endorsement of the platform.
Register interest
Tell us your role and context. We use this to prioritise outreach as the platform is finalised.
Founders / researchers
Share stage and institution so we can route you appropriately.
Read for founders